The FDA has granted Medtronic approval to market its Viva system, an implantable device used to treat heart failure by resynchronizing the beating of a patient's heart. Patients who received the device saw 21% reduced hospitalizations during the first year of implantation compared with those using traditional systems, a company official said.
Medtronic gains FDA OK for heart resynchronization device
SmartBrief Job Listings for Health Care
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Leadership Recruiting Manager||
|Strategic Partner Relationship Executive||
Geisinger Health System